Skip to content

??Precise Assessment of Axial Spondyloarthritis Activity Based on Dual-Energy CT and Magnetic Resonance T2-Mapping Techniques and Its Mechanistic Impact on Cerebral Glymphatic System Function?

??Precise Assessment of Axial Spondyloarthritis Activity Based on Dual-Energy CT and Magnetic Resonance T2-Mapping Techniques and Its Mechanistic Impact on Cerebral Glymphatic System Function?

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111024
Enrollment
Unknown
Registered
2025-10-23
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

axial spondyloarthritis

Interventions

axial spondyloarthritis group:N/A
healthy control group:N/A

Sponsors

General Hospital of Center Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria for the axSpA Group 1. Aged 18-45 years, regardless of gender. 2. Meeting the 2023 expert consensus on the diagnosis and treatment of axial spondyloarthritis and the ASAS classification criteria. 3. Able to cooperate in completing all examination items. 4. Voluntarily participate in the study and sign the informed consent form. Inclusion Criteria for the Healthy Control Group 1. Age and gender matched with the disease group (+/-5 years). 2. No history of joint diseases. 3. Normal laboratory immune indicators. 4. Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for the axSpA Group 1. Comorbid with other rheumatic immune diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus). 2. History of central nervous system diseases (e.g., stroke, epilepsy, traumatic brain injury). 3. Contraindications for MRI examination (e.g., cardiac pacemaker, metal implants). 4. Severe hepatic or renal insufficiency. 5. Pregnant or lactating women. 6. Participation in other clinical studies within the past 3 months. Exclusion Criteria for the Healthy Control Group 1. History of chronic pain. 2. Having a first-degree relative with spondyloarthritis. 3. HLA-B27 positive. 4. The remaining criteria are the same as the exclusion criteria for the axSpA group.

Design outcomes

Primary

MeasureTime frame
CT value;T2 value;Mobility Score;cerebral functional paremeters;cerebral structural paremeters;

Countries

China

Contacts

Public ContactHuang Wencai

General Hospital of Center Theater Command

SIRVONVEY@163.com+86 180 6202 8810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026